LT - B ląstelių kiekį mažinantys agentai, tokie kaip anti-CD20 antikūnai ar jų fragmentai, skirti lėtinio nuovargio sindromo gydymui
EN - B-CELL DEPLETING AGENTS, LIKE ANTI-CD20 ANTIBODIES OR FRAGMENTS THEREOF FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07K 16/28 |
(2006.01) |
|
|
A61K 39/395 |
(2006.01) |
European patent
(11) |
Number of the document |
2235060 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
09700128.3 |
|
Date of filing the European patent application |
2009-01-02 |
(97) |
Date of publication of the European application |
2010-10-06 |
(45) |
Date of publication and mention of the grant of the patent |
2017-03-29
|
(46) |
Date of publication of the claims translation |
2017-07-25
|
PCT application
(86) |
Number |
PCT/EP2009/000003 |
|
Date |
2009-01-02 |
PCT application publication
(87) |
Number |
WO 2009/083602 |
|
Date |
2009-07-09 |
Priority applications
(30) |
Number |
Date |
Country code |
|
08000006 |
2008-01-02
|
EP |
|
18551 |
2008-01-02
|
US |
Inventors
(72) |
MELLA, Olav, NO
FLUGE, Oystein, NO
|
Grantee
(73) |
Bergen Teknologioverf ring AS,
Thorm hlensgate 55, 5008 Bergen,
NO
|
Attorney or representative
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
(54) |
B ląstelių kiekį mažinantys agentai, tokie kaip anti-CD20 antikūnai ar jų fragmentai, skirti lėtinio nuovargio sindromo gydymui |
|
B-CELL DEPLETING AGENTS, LIKE ANTI-CD20 ANTIBODIES OR FRAGMENTS THEREOF FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2019-05-21 |
11 |
433.50
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2020-01-02 |